<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Jing ZL</submitter><funding>the National Natural Science Foundation of China</funding><pagination>6053</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10937991</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>14(1)</volume><pubmed_abstract>The bioactivity of interferon-γ (IFN-γ) in cancer cells in the tumor microenvironment (TME) is not well understood in the current immunotherapy era. We found that IFN-γ has an immunosuppressive effect on colorectal cancer (CRC) cells. The tumor volume in immunocompetent mice was significantly increased after subcutaneous implantation of murine CRC cells followed by IFN-γ stimulation, and RNA sequencing showed high expression of B7 homologous protein 4 (B7H4) in these tumors. B7H4 promotes CRC cell growth by inhibiting the release of granzyme B (GzmB) from CD8&lt;sup>+&lt;/sup> T cells and accelerating apoptosis in CD8&lt;sup>+&lt;/sup> T cells. Furthermore, interferon regulatory factor 1 (IRF1), which binds to the B7H4 promoter, is positively associated with IFN-γ stimulation-induced expression of B7H</pubmed_abstract><journal>Scientific reports</journal><pubmed_title>Interferon-γ in the tumor microenvironment promotes the expression of B7H4 in colorectal cancer cells, thereby inhibiting cytotoxic T cells.</pubmed_title><pmcid>PMC10937991</pmcid><funding_grant_id>81672453</funding_grant_id><funding_grant_id>81702359</funding_grant_id><pubmed_authors>Liu GL</pubmed_authors><pubmed_authors>Feng N</pubmed_authors><pubmed_authors>Zhou N</pubmed_authors><pubmed_authors>Xu DY</pubmed_authors><pubmed_authors>Ma LL</pubmed_authors><pubmed_authors>Tang N</pubmed_authors><pubmed_authors>Lei Y</pubmed_authors><pubmed_authors>Deng YJ</pubmed_authors><pubmed_authors>Jing ZL</pubmed_authors><pubmed_authors>Tang MS</pubmed_authors><pubmed_authors>Tong GH</pubmed_authors></additional><is_claimable>false</is_claimable><name>Interferon-γ in the tumor microenvironment promotes the expression of B7H4 in colorectal cancer cells, thereby inhibiting cytotoxic T cells.</name><description>The bioactivity of interferon-γ (IFN-γ) in cancer cells in the tumor microenvironment (TME) is not well understood in the current immunotherapy era. We found that IFN-γ has an immunosuppressive effect on colorectal cancer (CRC) cells. The tumor volume in immunocompetent mice was significantly increased after subcutaneous implantation of murine CRC cells followed by IFN-γ stimulation, and RNA sequencing showed high expression of B7 homologous protein 4 (B7H4) in these tumors. B7H4 promotes CRC cell growth by inhibiting the release of granzyme B (GzmB) from CD8&lt;sup>+&lt;/sup> T cells and accelerating apoptosis in CD8&lt;sup>+&lt;/sup> T cells. Furthermore, interferon regulatory factor 1 (IRF1), which binds to the B7H4 promoter, is positively associated with IFN-γ stimulation-induced expression of B7H</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Mar</publication><modification>2026-07-14T21:00:30.719Z</modification><creation>2026-06-24T03:07:05.953Z</creation></dates><accession>S-EPMC10937991</accession><cross_references><pubmed>38480774</pubmed><doi>10.1038/s41598-024-56681-3</doi></cross_references></HashMap>